Quent Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $211K | Sell |
475
-38
| -7% | -$16.9K | 0.02% | 265 |
|
2025
Q1 | $249K | Buy |
513
+22
| +4% | +$10.7K | 0.03% | 221 |
|
2024
Q4 | $198K | Sell |
491
-49
| -9% | -$19.7K | 0.02% | 263 |
|
2024
Q3 | $251K | Buy |
540
+117
| +28% | +$54.4K | 0.03% | 294 |
|
2024
Q2 | $198K | Buy |
423
+24
| +6% | +$11.2K | 0.02% | 316 |
|
2024
Q1 | $167K | Buy |
399
+99
| +33% | +$41.4K | 0.02% | 368 |
|
2023
Q4 | $122K | Buy |
300
+118
| +65% | +$48K | 0.02% | 401 |
|
2023
Q3 | $63.3K | Buy |
182
+96
| +112% | +$33.4K | 0.01% | 529 |
|
2023
Q2 | $30.3K | Buy |
86
+41
| +91% | +$14.4K | ﹤0.01% | 705 |
|
2023
Q1 | $14.2K | Sell |
45
-16
| -26% | -$5.04K | ﹤0.01% | 848 |
|
2022
Q4 | $17.6K | Buy |
61
+12
| +24% | +$3.47K | ﹤0.01% | 785 |
|
2022
Q3 | $14K | Buy |
49
+5
| +11% | +$1.43K | ﹤0.01% | 811 |
|
2022
Q2 | $12K | Buy |
44
+8
| +22% | +$2.18K | ﹤0.01% | 800 |
|
2022
Q1 | $9K | Sell |
36
-56
| -61% | -$14K | ﹤0.01% | 937 |
|
2021
Q4 | $20K | Buy |
+92
| New | +$20K | ﹤0.01% | 721 |
|